tiprankstipranks
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Holding SPRY?
Track your performance easily

ARS Pharmaceuticals (SPRY) Financial Statements

323 Followers

ARS Pharmaceuticals Financial Overview

ARS Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.507; its P/E ratio is -28.60; ARS Pharmaceuticals is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 2.07M$ 500.00K---
Gross Profit$ 2.07M$ 500.00K---
EBIT$ -21.75M$ -15.34M$ -13.19M$ -10.23M$ -17.98M
EBITDA$ -23.55M$ -15.34M$ -13.19M$ -10.23M$ -17.96M
Net Income Common Stockholders$ -19.13M$ -12.52M$ -10.29M$ -7.17M$ -14.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 204.62M$ 218.74M$ 223.63M$ 228.36M$ 241.90M
Total Assets$ 217.60M$ 221.97M$ 227.58M$ 233.19M$ 248.56M
Total Debt$ 102.00K$ 160.00K$ 217.00K$ 274.00K$ 327.00K
Net Debt$ -204.52M$ -218.58M$ -223.41M$ -228.09M$ -241.57M
Total Liabilities$ 16.62M$ 6.72M$ 3.71M$ 2.43M$ 11.27M
Stockholders Equity$ 200.98M$ 215.24M$ 223.87M$ 230.76M$ 237.28M
Cash Flow-
Free Cash Flow$ -14.61M$ -7.32M$ -6.79M$ -17.31M$ -12.81M
Operating Cash Flow$ -14.47M$ -7.28M$ -6.71M$ -17.41M$ -12.76M
Investing Cash Flow$ 16.82M$ -12.65M$ -8.51M$ 26.04M$ -46.64M
Financing Cash Flow$ 680.00K$ 545.00K$ 258.00K$ 1.80M$ 921.00K
Currency in USD

ARS Pharmaceuticals Earnings and Revenue History

ARS Pharmaceuticals Debt to Assets

ARS Pharmaceuticals Cash Flow

ARS Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis